Abdulaziz O

References (3)

Title : In Silico and ADMET Studies of Spiro-Quinazoline Compounds as Acetylcholine Esterase Inhibitors Against Alzheimer's Disease - Aljuaid_2024_CNS.Neurol.Disord.Drug.Targets__
Author(s) : Aljuaid A , Abdulaziz O , Allahyani M , Almehmadi M , Alzahrani AYA , Verma S , Yusuf M , Asif M
Ref : CNS Neurol Disord Drug Targets , : , 2024
Abstract :
PubMedSearch : Aljuaid_2024_CNS.Neurol.Disord.Drug.Targets__
PubMedID: 39473101

Title : Multipotent Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease: Synthesis, Biological Analysis and Molecular Docking Study of Benzimidazole-Based Thiazole Derivatives - Hussain_2022_Molecules_27_6087
Author(s) : Hussain R , Ullah H , Rahim F , Sarfraz M , Taha M , Iqbal R , Rehman W , Khan S , Shah SAA , Hyder S , Alhomrani M , Alamri AS , Abdulaziz O , Abdelaziz MA
Ref : Molecules , 27 :6087 , 2022
Abstract :
PubMedSearch : Hussain_2022_Molecules_27_6087
PubMedID: 36144820

Title : Neuroprotective Potential of Synthetic Mono-Carbonyl Curcumin Analogs Assessed by Molecular Docking Studies - Hussain_2021_Molecules_26_
Author(s) : Hussain H , Ahmad S , Shah SWA , Ghias M , Ullah A , Rahman SU , Kamal Z , Khan FA , Khan NM , Muhammad J , Almehmadi M , Abdulaziz O , Alghamdi S
Ref : Molecules , 26 : , 2021
Abstract :
PubMedSearch : Hussain_2021_Molecules_26_
PubMedID: 34885751